ad6548b723
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
- Source: inbox/queue/2026-04-24-arpa-h-evident-139m-behavioral-health-psychedelics.md - Domain: health - Claims: 0, Entities: 4 - Enrichments: 3 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
32 lines
No EOL
1.5 KiB
Markdown
32 lines
No EOL
1.5 KiB
Markdown
# INVI MindHealth
|
|
|
|
**Location:** Denver, Colorado
|
|
|
|
**Focus:** Real-time biomarker platform for neuromodulation and psychedelic therapies
|
|
|
|
**Stage:** Selected for ARPA-H EVIDENT initiative
|
|
|
|
## Technology Platform
|
|
|
|
Real-time biomarker monitoring system designed to:
|
|
- Track physiological responses during neuromodulation treatments
|
|
- Monitor psychedelic therapy sessions
|
|
- Generate FDA-ready clinical endpoint data
|
|
|
|
## Strategic Position
|
|
|
|
INVI MindHealth represents the biomarker infrastructure layer for behavioral health interventions—addressing the measurement gap that has historically limited psychedelic and neuromodulation research. Real-time monitoring enables:
|
|
1. Objective outcome measurement beyond self-reported scales
|
|
2. Safety monitoring during treatment sessions
|
|
3. Dose-response optimization
|
|
4. Mechanistic understanding of therapeutic effects
|
|
|
|
## Timeline
|
|
|
|
- **2026-04-24** — Selected as ARPA-H EVIDENT research team for real-time biomarker platform development
|
|
|
|
## Analysis
|
|
|
|
The biomarker platform addresses a critical gap in psychedelic research: functional unblinding (patients and clinicians knowing who received active drug) invalidates self-reported outcomes in highly psychoactive compounds. Objective biomarkers could provide unblinding-resistant endpoints, strengthening regulatory submissions.
|
|
|
|
ARPA-H's selection of a biomarker platform company (rather than only drug developers) signals recognition that measurement infrastructure is a binding constraint on FDA approval pathways for behavioral health interventions. |